Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH) — Stella

Home/Idiopathic Pulmonary Arterial Hypertension/Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

View on ClinicalTrials.gov

Recruiting

Back to Idiopathic Pulmonary Arterial Hypertension trials

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Sponsor

Vanderbilt University Medical Center

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~75 participants

Started

January 2023

Primary completion

September 2027

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.